StockData
AstraZeneca PLC logo

AstraZeneca PLC

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca Reported (IFRS) operating profit by Quarter

Reported (IFRS) operating profit ($M) ($M)

QuarterlyAnnual

AstraZeneca Reported (IFRS) operating profit: $3,164M in Q2 2026, down 9.8% from a year earlier.

Latest, Q2 2026
3,164
Period ended Jun 30, 2026
Change on a year earlier
-9.8%
3,508 in Q2 2025
History
26 quarters
Since Q2 2017
Sources
25
Documents cited below

Where the Q2 2026 figure comes from

“|| Operating profit | | 3,164 | | | 100 | | | 1,546 | | 348 | | 5,158 | 12 | 10”

Source: Form 6-K FY2026Q2 Earnings Release ↗

Reported in Form 6-K / 20-F Consolidated Income Statement.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedReported (IFRS) operating profit ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20263,164-9.8%Form 6-K FY2026Q2 Earnings Release ↗
Q1 2026Mar 31, 20264,246+15.6%Form 6-K FY2026Q1 Earnings Release ↗
Q4 2025Dec 31, 20252,978+46.3%Form 6-K FY2025Q4 Earnings Release ↗
Q3 2025Sep 30, 20253,583+70.1%Form 6-K FY2025Q3 Earnings Release ↗
Q2 2025Jun 30, 20253,508+27.7%Form 6-K FY2025Q2 Earnings Release ↗
Q1 2025Mar 31, 20253,674+17.9%Form 6-K FY2025Q1 Earnings Release ↗
Q4 2024Dec 31, 20242,036+65.0%Form 6-K FY2024Q4 Earnings Release ↗
Q3 2024Sep 30, 20242,106+7.8%Form 6-K FY2024Q3 Earnings Release ↗
Q2 2024Jun 30, 20242,746+11.8%Form 6-K FY2024Q2 Earnings Release ↗
Q1 2024Mar 31, 20243,115+22.2%Form 6-K FY2024Q1 Earnings Release ↗
Q4 2023Dec 31, 20231,234+12.8%Form 6-K FY2023Q4 Earnings Release ↗
Q3 2023Sep 30, 20231,954+56.9%Form 6-K FY2023Q3 Earnings Release ↗
Q2 2023Jun 30, 20232,456+355.7%Form 6-K FY2023Q2 Earnings Release ↗
Q1 2023Mar 31, 20232,549+190.3%Form 6-K FY2023Q1 Earnings Release ↗
Q4 2022Dec 31, 20221,094-474.7%Form 6-K FY2022Q4 Earnings Release ↗
Q3 2022Sep 30, 20221,245–Form 6-K FY2022Q3 Earnings Release ↗

Cite this data

StockData. (2026). AstraZeneca Reported (IFRS) operating profit ($M), quarterly Q2 2017–Q2 2026 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/rep-op-profit-cmp

See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.